250 related articles for article (PubMed ID: 34240269)
1. Bis(ethylmaltolato)oxidovanadium (IV) alleviates neuronal apoptosis through regulating peroxisome proliferator-activated receptor γ in a triple transgenic animal model of Alzheimer's disease.
He Z; Song J; Li X; Li X; Zhu H; Wu C; Xiao W; Du X; Ni J; Li N; Liu Q
J Biol Inorg Chem; 2021 Aug; 26(5):551-568. PubMed ID: 34240269
[TBL] [Abstract][Full Text] [Related]
2. Bis(ethylmaltolato)oxidovanadium (IV) mitigates neuronal apoptosis resulted from amyloid-beta induced endoplasmic reticulum stress through activating peroxisome proliferator-activated receptor γ.
He Z; Wang M; Zhao Q; Li X; Liu P; Ren B; Wu C; Du X; Li N; Liu Q
J Inorg Biochem; 2020 Jul; 208():111073. PubMed ID: 32466853
[TBL] [Abstract][Full Text] [Related]
3. Bis(ethylmaltolato)oxidovanadium (IV) attenuates amyloid-beta-mediated neuroinflammation by inhibiting NF-κB signaling pathway via a PPARγ-dependent mechanism.
He Z; Li X; Han S; Ren B; Hu X; Li N; Du X; Ni J; Yang X; Liu Q
Metallomics; 2021 Jul; 13(7):. PubMed ID: 34124763
[TBL] [Abstract][Full Text] [Related]
4. Bis(ethylmaltolato)oxidovanadium(iv) inhibited the pathogenesis of Alzheimer's disease in triple transgenic model mice.
He Z; Han S; Wu C; Liu L; Zhu H; Liu A; Lu Q; Huang J; Du X; Li N; Xie Q; Wan L; Ni J; Chen L; Yang X; Liu Q
Metallomics; 2020 Apr; 12(4):474-490. PubMed ID: 31970356
[TBL] [Abstract][Full Text] [Related]
5. An Adequate Supply of Bis(ethylmaltolato)oxidovanadium(IV) Remarkably Reversed the Pathological Hallmarks of Alzheimer's Disease in Triple-Transgenic Middle-Aged Mice.
He Z; Zheng L; Zhao X; Li X; Xue H; Zhao Q; Ren B; Li N; Ni J; Zhang Y; Liu Q
Biol Trace Elem Res; 2022 Jul; 200(7):3248-3264. PubMed ID: 35031965
[TBL] [Abstract][Full Text] [Related]
6. The Protective Effect of Vanadium on Cognitive Impairment and the Neuropathology of Alzheimer's Disease in APPSwe/PS1dE9 Mice.
He Z; Han S; Zhu H; Hu X; Li X; Hou C; Wu C; Xie Q; Li N; Du X; Ni J; Liu Q
Front Mol Neurosci; 2020; 13():21. PubMed ID: 32210760
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound.
He Z; You G; Liu Q; Li N
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769364
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone rescues human neural stem cells from amyloid-beta induced ER stress via PPARγ dependent signaling.
Lin CH; Nicol CJB; Cheng YC; Chen SJ; Yen CH; Huang RN; Chiang MC
Exp Cell Res; 2018 Sep; 370(2):312-321. PubMed ID: 29964054
[TBL] [Abstract][Full Text] [Related]
9. Esculentoside A alleviates cognitive deficits and amyloid pathology through peroxisome proliferator-activated receptor γ-dependent mechanism in an Alzheimer's disease model.
He Z; Li X; Wang Z; Tu S; Feng J; Du X; Ni J; Li N; Liu Q
Phytomedicine; 2022 Apr; 98():153956. PubMed ID: 35151213
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of luteolin against amyloid beta-induced oxidative stress and mitochondrial impairments through peroxisome proliferator-activated receptor γ-dependent mechanism in Alzheimer's disease.
He Z; Li X; Wang Z; Cao Y; Han S; Li N; Cai J; Cheng S; Liu Q
Redox Biol; 2023 Oct; 66():102848. PubMed ID: 37597424
[TBL] [Abstract][Full Text] [Related]
11. Whey protein powder with milk fat globule membrane attenuates Alzheimer's disease pathology in 3×Tg-AD mice by modulating neuroinflammation through the peroxisome proliferator-activated receptor γ signaling pathway.
Li Y; Zhang ZH; Huang SL; Yue ZB; Yin XS; Feng ZQ; Zhang XG; Song GL
J Dairy Sci; 2023 Aug; 106(8):5253-5265. PubMed ID: 37414601
[TBL] [Abstract][Full Text] [Related]
12. Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation.
Li Z; Li H; Zhao C; Lv C; Zhong C; Xin W; Zhang W
CNS Neurol Disord Drug Targets; 2015; 14(3):360-9. PubMed ID: 25714973
[TBL] [Abstract][Full Text] [Related]
13. Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease.
Wang ZJ; Zhao F; Wang CF; Zhang XM; Xiao Y; Zhou F; Wu MN; Zhang J; Qi JS; Yang W
J Alzheimers Dis; 2019; 72(4):1217-1231. PubMed ID: 31683484
[TBL] [Abstract][Full Text] [Related]
14. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.
Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A
J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626
[TBL] [Abstract][Full Text] [Related]
15. Chrysophanol exerts neuroprotective effects via interfering with endoplasmic reticulum stress apoptotic pathways in cell and animal models of Alzheimer's disease.
Li X; Cheng Y; Qin Y; Gao H; Wang G; Song H; Wang Y; Cai B
J Pharm Pharmacol; 2022 Jan; 74(1):32-40. PubMed ID: 34791341
[TBL] [Abstract][Full Text] [Related]
16. Curcumin protects neurons against oxygen-glucose deprivation/reoxygenation-induced injury through activation of peroxisome proliferator-activated receptor-γ function.
Liu ZJ; Liu HQ; Xiao C; Fan HZ; Huang Q; Liu YH; Wang Y
J Neurosci Res; 2014 Nov; 92(11):1549-59. PubMed ID: 24975470
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV prevents Aβ
Wang X; Xu W; Chen H; Li W; Li W; Zhu G
Brain Res; 2020 Nov; 1747():147041. PubMed ID: 32739157
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1.
Wang X; Wang Y; Hu JP; Yu S; Li BK; Cui Y; Ren L; Zhang LD
Mol Neurobiol; 2017 May; 54(4):2939-2949. PubMed ID: 27023226
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.
Liu Y; Zhang Y; Liu P; Bai H; Li X; Xiao J; Yuan Q; Geng S; Yin H; Zhang H; Wang Z; Li J; Wang S; Wang Y
Eur J Pharmacol; 2019 Jan; 843():134-144. PubMed ID: 30412727
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models.
Zhao Y; Calon F; Julien C; Winkler JW; Petasis NA; Lukiw WJ; Bazan NG
PLoS One; 2011 Jan; 6(1):e15816. PubMed ID: 21246057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
